Literature DB >> 2040931

Neonatal opiate abstinence syndrome in term and preterm infants.

T M Doberczak1, S R Kandall, I Wilets.   

Abstract

Data on 178 term and 34 preterm infants born to methadone-maintained mothers were analyzed to assess the effects of neonatal opiate abstinence in infants of varying gestational ages. More mothers in the term group (79%) than in the preterm group (53%) had abused other drugs during pregnancy (p less than 0.001). Mean (+/- SD) gestational age was 39.5 weeks +/- 1.4 for term infants and 34.3 weeks +/- 2.6 for preterm infants. On the basis of a semiobjective symptom scoring scale, term infants had more severe abstinence symptoms and more prominent central nervous system manifestations than preterm infants. The severity of abstinence symptoms correlated with maternal methadone dosage in both term and preterm infants. Maternal multiple drug abuse (e.g., heroin, cocaine) did not influence severity of abstinence symptoms in either group. More term infants (145/178) than preterm infants (20/34) required treatment for these symptoms (p less than 0.005). In 13 of 178 term infants, compared with 1 of 34 preterm infants, abstinence-related seizures developed. Peak severity occurred 1 to 2 days earlier in term than in preterm infants. A less severe abstinence syndrome in preterm infants may be due to (1) developmental immaturity of either dendritic ramifications, specific opiate receptors, or neurotransmitter function, or (2) reduced total drug exposure during the intrauterine period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040931     DOI: 10.1016/s0022-3476(05)82214-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

1.  An unusual cause of convulsions in a newborn infant.

Authors:  N R Ruggins; S Watkin; N Rutter
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

Review 2.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

3.  kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.

Authors:  J A Gurwell; M J Duncan; K Maderspach; A Stiene-Martin; R P Elde; K F Hauser
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

4.  A survey of the management of neonatal opiate withdrawal in England and Wales.

Authors:  C L Morrison; C Siney
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

5.  Treatment of Prescription Opioid Use Disorder in Pregnant Women.

Authors:  Constance Guille; Kelly S Barth; Julio Mateus; Jenna L McCauley; Kathleen T Brady
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

6.  Methadone maintenance treatment. Pregnant women taking methadone should be warned about withdrawal symptoms in babies.

Authors:  S Kempley
Journal:  BMJ       Date:  1995-02-18

7.  Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

Authors:  C A Kuschel; L Austerberry; M Cornwell; R Couch; R S H Rowley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

8.  Neonatal abstinence syndrome--postnatal ward versus neonatal unit management.

Authors:  Tolulope Saiki; Silke Lee; Simon Hannam; Anne Greenough
Journal:  Eur J Pediatr       Date:  2009-05-14       Impact factor: 3.183

9.  The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.

Authors:  Lara S Lemon; Ashley Naimi; Steve N Caritis; Robert W Platt; Raman Venkataramanan; Lisa M Bodnar
Journal:  Paediatr Perinat Epidemiol       Date:  2018-01-26       Impact factor: 3.980

10.  Attenuation by dextromethorphan on the higher liability to morphine-induced reward, caused by prenatal exposure of morphine in rat offspring.

Authors:  Ling-Yi Wu; Jain-Fang Chen; Pao-Luh Tao; Eagle Yi-Kung Huang
Journal:  J Biomed Sci       Date:  2009-11-25       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.